 |
InterPro: IPR002403 Cytochrome P450, E-class, group IV
Protein matches
|
UniProtKB Matches: 2398 proteins |
|
Accession
|
IPR002403 Cyt_P450_E_grp-IV |
Type
|
Family |
Signatures
|
|
InterPro Relationships
|
|
Parent
|
IPR001128 Cytochrome P450
|
|
Contains
|
IPR017972 Cytochrome P450, conserved site
IPR017973 Cytochrome P450, C-terminal
|
GO Term annotation
|
|
Function
|
GO:0004497 monooxygenase activity
GO:0005506 iron ion binding
GO:0020037 heme binding
|
|
InterPro annotation
|
|
Entry Details in BioMart
|
Abstract
|
Cytochrome P450 enzymes are a superfamily of haem-containing mono-oxygenases that are found in all kingdoms of life, and which show extraordinary diversity in their reaction chemistry. In mammals, these proteins are found primarily in microsomes of hepatocytes and other cell types, where they oxidise steroids, fatty acids and xenobiotics, and are important for the detoxification and clearance of various compounds, as well as for hormone synthesis and breakdown, cholesterol synthesis and vitamin D metabolism. In plants, these proteins are important for the biosynthesis of several compounds such as hormones, defensive compounds and fatty acids. In bacteria, they are important for several metabolic processes, such as the biosynthesis of antibiotic erythromycin in Saccharopolyspora erythraea (Streptomyces erythraeus).
Cytochrome P450 enzymes use haem to oxidise their substrates, using protons derived from NADH or NADPH to split the oxygen so a single atom can be added to a substrate. They also require electrons, which they receive from a variety of redox partners. In certain cases, cytochrome P450 can be fused to its redox partner to produce a bi-functional protein, such as with P450BM-3 from Bacillus megaterium [1], which has haem and flavin domains.
Organisms produce many different cytochrome P450 enzymes (at least 58 in humans), which together with alternative splicing can provide a wide array of enzymes with different substrate and tissue specificities. Individual cytochrome P450 proteins follow the nomenclature: CYP, followed by a number (family), then a letter (subfamily), and another number (protein); e.g. CYP3A4 is the fourth protein in family 3, subfamily A. In general, family members should share >40% identity, while subfamily members should share >55% identity.
Cytochrome P450 proteins can also be grouped by two different schemes. One scheme was based on a taxonomic split: class I (prokaryotic/mitochondrial) and class II (eukaryotic microsomes). The other scheme was based on the number of components in the system: class B (3-components) and class E (2-components). These classes merge to a certain degree. Most prokaryotes and mitochondria (and fungal CYP55) have 3-component systems (class I/class B) - a FAD-containing flavoprotein (NAD(P)H-dependent reductase), an iron-sulphur protein and P450. Most eukaryotic microsomes have 2-component systems (class II/class E) - NADPH:P450 reductase (FAD and FMN-containing flavoprotein) and P450. There are exceptions to this scheme, such as 1-component systems that resemble class E enzymes [2, 3, 4]. The class E enzymes can be further subdivided into five sequence clusters, groups I-V, each of which may contain more than one cytochrome P450 family (eg, CYP1 and CYP2 are both found in group I). The divergence of the cytochrome P450 superfamily into B- and E-classes, and further divergence into stable clusters within the E-class, appears to be very ancient, occurring before the appearance of eukaryotes.
This entry represents class E cytochrome P450 proteins that fall into sequence cluster group IV. Group IV comprises the CYP7 (cholesterol 7-alpha-hydroxylase) and CYP51 (lanosterol 14-alpha-demethylase) families, which show significant sequence similarity even though there is no apparent functional resemblance [5]. The CYP8 (prostacyclin synthase) family also falls into this group, and shows high sequence similarity to CYP7 members [6].
More information about these proteins can be found at Protein of the Month: Cytochrome P450 [7].
|
Structural links
|
|
Database links
|
|
Publications
|
|
1.
|
Munro AW, Girvan HM, McLean KJ.
Cytochrome P450--redox partner fusion enzymes.
Biochim. Biophys. Acta 1770 345-59 2007
[PubMed: 17023115]
http://dx.doi.org/10.1016/j.bbagen.2006.08.018
|
|
2.
|
McLean KJ, Sabri M, Marshall KR, Lawson RJ, Lewis DG, Clift D, Balding PR, Dunford AJ, Warman AJ, McVey JP, Quinn AM, Sutcliffe MJ, Scrutton NS, Munro AW.
Biodiversity of cytochrome P450 redox systems.
Biochem. Soc. Trans. 33 796-801 2005
[PubMed: 16042601]
http://www.biochemsoctrans.org/bst/033/0796/bst0330796.htm
|
|
3.
|
Nelson DR, Zeldin DC, Hoffman SM, Maltais LJ, Wain HM, Nebert DW.
Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants.
Pharmacogenetics 14 1-18 2004
[PubMed: 15128046]
http://dx.doi.org/10.1097/00008571-200401000-00001
|
|
4.
|
Degtyarenko KN.
Structural domains of P450-containing monooxygenase systems.
Protein Eng. 8 737-47 1995
[PubMed: 8637843]
http://dx.doi.org/10.1093/protein/8.8.737
|
|
5.
|
Gotoh O.
Evolution and differentiation of P-450 genes.
255-72 1993
|
|
6.
|
Hara S, Miyata A, Yokoyama C, Inoue H, Brugger R, Lottspeich F, Ullrich V, Tanabe T.
Isolation and molecular cloning of prostacyclin synthase from bovine endothelial cells.
J. Biol. Chem. 269 19897-903 1994
[PubMed: 8051072]
http://intl.jbc.org/cgi/reprint/269/31/19897.pdf
|
|
7.
|
McDowall J.
Protein of the Month ? Cytochrome P450.
2006
|
Additional Reading
|
|
Nebert DW, Gonzalez FJ.
P450 genes: structure, evolution, and regulation.
Annu. Rev. Biochem. 56 1987 945-93
[PubMed: 3304150]
http://dx.doi.org/10.1146/annurev.bi.56.070187.004501
|
|
Podust LM, Yermalitskaya LV, Lepesheva GI, Podust VN, Dalmasso EA, Waterman MR.
Estriol bound and ligand-free structures of sterol 14alpha-demethylase.
Structure 12 2004 1937-45
[PubMed: 15530358]
http://dx.doi.org/10.1016/j.str.2004.08.009
|
|
Podust LM, von Kries JP, Eddine AN, Kim Y, Yermalitskaya LV, Kuehne R, Ouellet H, Warrier T, Altekoster M, Lee JS, Rademann J, Oschkinat H, Kaufmann SH, Waterman MR.
Small-molecule scaffolds for CYP51 inhibitors identified by high-throughput screening and defined by X-ray crystallography.
Antimicrob. Agents Chemother. 51 2007 3915-23
[PubMed: 17846131]
http://dx.doi.org/10.1128/AAC.00311-07
|
|
Podust LM, Stojan J, Poulos TL, Waterman MR.
Substrate recognition sites in 14alpha-sterol demethylase from comparative analysis of amino acid sequences and X-ray structure of Mycobacterium tuberculosis CYP51.
J. Inorg. Biochem. 87 2001 227-35
[PubMed: 11744060]
http://dx.doi.org/10.1016/S0162-0134(01)00388-9
|
|
Nelson DR, Kamataki T, Waxman DJ, Guengerich FP, Estabrook RW, Feyereisen R, Gonzalez FJ, Coon MJ, Gunsalus IC, Gotoh O.
The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature.
DNA Cell Biol. 12 1993 1-51
[PubMed: 7678494]
|
|
Podust LM, Poulos TL, Waterman MR.
Crystal structure of cytochrome P450 14alpha -sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors.
Proc. Natl. Acad. Sci. U.S.A. 98 2001 3068-73
[PubMed: 11248033]
http://dx.doi.org/10.1073/pnas.061562898
|
|
Eddine AN, von Kries JP, Podust MV, Warrier T, Kaufmann SH, Podust LM.
X-ray structure of 4,4'-dihydroxybenzophenone mimicking sterol substrate in the active site of sterol 14alpha-demethylase (CYP51).
J. Biol. Chem. 283 2008 15152-9
[PubMed: 18367444]
http://dx.doi.org/10.1074/jbc.M801145200
|
|